Outcomes of Richter’s transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Outcomes of Richter’s transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database
Authors
Keywords
-
Journal
ANNALS OF HEMATOLOGY
Volume 100, Issue 10, Pages 2513-2519
Publisher
Springer Science and Business Media LLC
Online
2021-07-19
DOI
10.1007/s00277-021-04603-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Richter’s transformation in patients with chronic lymphocytic leukaemia: a Nationwide Epidemiological Study
- (2020) Yasmin Ben-Dali et al. LEUKEMIA & LYMPHOMA
- A multicenter phase II study of venetoclax plus dose-adjusted R-EPOCH (VR-EPOCH) for Richter’s syndrome.
- (2020) Matthew Steven Davids et al. JOURNAL OF CLINICAL ONCOLOGY
- Richter transformation in chronic lymphocytic leukemia (CLL)—a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials
- (2020) O. Al-Sawaf et al. LEUKEMIA
- Clinical outcome and prognostic factors of patients with Richter syndrome: real‐world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC)
- (2020) Pau Abrisqueta et al. BRITISH JOURNAL OF HAEMATOLOGY
- Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
- (2020) Jeremy S Abramson et al. LANCET
- Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome
- (2020) Adam S. Kittai et al. Blood Advances
- Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinib
- (2020) Paul J. Hampel et al. Blood Advances
- PHASE I/II STUDY OF UMBRALISIB (TGR-1202) IN COMBINATION WITH UBLITUXIMAB (TG-1101) AND PEMBROLIZUMAB IN PATIENTS WITH REL/REF CLL AND RICHTER'S TRANSFORMATION
- (2019) A.R. Mato et al. HEMATOLOGICAL ONCOLOGY
- Biology and treatment of Richter syndrome
- (2018) Davide Rossi et al. BLOOD
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation
- (2016) Mohamed A. Kharfan-Dabaja et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis—with comparison to Hodgkin-like lesion
- (2016) Wenbin Xiao et al. HUMAN PATHOLOGY
- Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia
- (2015) Kami J. Maddocks et al. JAMA Oncology
- Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients
- (2013) Sameer A. Parikh et al. BRITISH JOURNAL OF HAEMATOLOGY
- Autologous and Allogeneic Stem-Cell Transplantation for Transformed Chronic Lymphocytic Leukemia (Richter's Syndrome): A Retrospective Analysis From the Chronic Lymphocytic Leukemia Subcommittee of the Chronic Leukemia Working Party and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
- (2012) Kate Cwynarski et al. JOURNAL OF CLINICAL ONCOLOGY
- The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation
- (2011) D. Rossi et al. BLOOD
- Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
- (2010) Robert Griffiths et al. BMC CANCER
- Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States
- (2010) Pareen J. Shenoy et al. CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started